PharmEasy had an IRR of -41% in H1 FY24, as per data released by Prosus in its half yearly financial statements PharmEasy was the second-biggest underperformer in Prosus’ global portfolio, with only ...
Homegrown B2B ecommerce solutions provider ElasticRun clinched an IRR of 31% for the Amsterdam-based investor in H1 FY24 Edtech platform Eruditus had an IRR of 22% IRR for Prosus, while foodtech ...
Bailador Technology Investments reports private portfolio return of 24.7% per annum for H1 FY25 Technology-focused capital fund increases valuation of several companies held Portfolio gain was 11.4 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results